The prognostic impact of minimal residual disease assessment after stem cell transplantation for chronic lymphocytic leukemia: is achievement of molecular remission worthwhile?

Leukemia. 2005 Jul;19(7):1135-8. doi: 10.1038/sj.leu.2403800.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Disease-Free Survival
  • Follow-Up Studies
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / diagnosis
  • Leukemia, Lymphocytic, Chronic, B-Cell / therapy*
  • Neoplasm, Residual / diagnosis
  • Neoplasm, Residual / therapy*
  • Prognosis
  • Remission Induction
  • Stem Cell Transplantation / adverse effects*
  • Stem Cell Transplantation / methods